By Dow Jones Business News,
May 15, 2014, 04:29:00 PM EDT
Pfizer Inc. ( PFE ) filed a Form 8K - Other Events - with the U.S Securities and Exchange Commission on May 15, 2014.
On May 15, 2014, Pfizer Inc. (the "Company") completed a public offering of $4,500,000,000 aggregate principal amount
of notes consisting of $500,000,000 aggregate principal amount of Floating Rate Notes due 2017, $1,000,000,000 aggregate
principal amount of 1.100% Notes due 2017, $1,500,000,000 aggregate principal amount of 2.100% Notes due 2019, $
1,000,000,000 aggregate principal amount of 3.400% Notes due 2024 and $500,000,000 aggregate principal amount of 4.400%
Notes due 2044 (together, the "Notes").
The offering of the Notes was made pursuant to the Company's shelf registration statement on Form S-3 (Registration
No. 333-181321) filed with the Securities and Exchange Commission on May 10, 2012.
In connection with the offering of the Notes, the Company entered into an underwriting agreement and related pricing
agreement, each dated May 12, 2014, with Merrill, Lynch, Pierce, Fenner & Smith Incorporated, Barclays Capital Inc.,
Deutsche Bank Securities Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named
The Notes were issued pursuant to an indenture, dated as of January 30, 2001, between the Company and The Bank of New
York Mellon (formerly known as The Bank of New York), as successor to JPMorgan Chase Bank (formerly known as The Chase
Manhattan Bank), as trustee, as supplemented by the Fourth Supplemental Indenture, dated as of May 15, 2014, between the
Company and The Bank of New York Mellon, as trustee.
The underwriting agreement, pricing agreement, indenture, fourth supplemental indenture (including forms of the
Notes) and press release related to the offering are filed as exhibits to this Form 8-K and are incorporated herein by
In addition, in connection with the offering of the Notes, the Company is filing a legal opinion regarding the
validity of the Notes, attached as Exhibit 5.1 to this Form 8-K.
The full text of this SEC filing can be retrieved at: http://www.sec.gov/Archives/edgar/data/78003/000119312514201187/
Any exhibits and associated documents for this SEC filing can be retrieved at: http://www.sec.gov/Archives/edgar/data/
Public companies must file a Form 8-K, or current report, with the SEC generally within four days of any event that
could materially affect a company's financial position or the value of its shares.
Access Investor Kit for Pfizer Inc.
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
(END) Dow Jones Newswires
Copyright (c) 2014 Dow Jones & Company, Inc.